Novo Nordisk faces setback as CLARION-CKD trial fails, leading to significant financial impairment

Novo Nordisk, a global leader in pharmaceuticals, has announced a major setback as its CLARION-CKD phase 3 trial failed to meet its primary endpoint, prompting ... Read More